Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations  |  Forex Crypto

Soligenix Inc. (SNGX)

2   0.06 (3.09%) 09-20 20:46
Open: 1.96 Pre. Close: 1.94
High: 2.04 Low: 1.93
Volume: 380,455 Market Cap: 60M
Soligenix, Inc. is a late-stage biopharmaceutical company, which engages in the development and commercialization of products to treat rare disease. The company is headquartered in Princeton, New Jersey and currently employs 14 full-time employees. The firm is focused on developing and commercializing products to treat rare diseases. The firm operates through two segments: BioTherapeutics and Vaccines/BioDefense. Its BioTherapeutics segment is developing a photodynamic therapy (SGX301) utilizing topical synthetic hypericin activated with safe visible light for the treatment of cutaneous T-cell lymphoma (CTCL), formulations of oral beclomethasone 17,21-dipropionate (BDP) for the prevention/treatment of gastrointestinal (GI) disorders characterized by severe inflammation, and its innate defense regulator (IDR) technology, dusquetide (SGX942) for the treatment of oral mucositis in head and neck cancer. Its Vaccines/BioDefense business segment includes active development programs for RiVax, its ricin toxin vaccine candidate, OrbeShield, its GI acute radiation syndrome (GI ARS) therapeutic candidate, and SGX943, its melioidosis therapeutic candidate.

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 2.033 - 2.043 2.043 - 2.052
Low: 1.937 - 1.947 1.947 - 1.956
Close: 1.954 - 1.971 1.971 - 1.985

Technical analysis

as of: 2020-09-18 4:35:44 PM
Stoxline posted a BUY today, same as yesterday. Upward movement continues.
Target: Six months: 2.44     One year: 2.69
Support: Support1: 1.75    Support2: 1.46
Resistance: Resistance1: 2.09    Resistance2: 2.30
Pivot: 1.93
Moving Average: MA(5): 1.94     MA(20): 1.98
MA(100): 1.96     MA(250): 1.76
MACD: MACD(12,26): -0.06     Signal(9): -0.07
Stochastic oscillator: %K(14,3): 48.48     %D(3): 42.80
RSI: RSI(14): 47.96
52-week: High: 3.54  Low: 0.85  Change(%): 118.9
Average Vol(K): 3-Month: 126391  10-Days: 31943

Price, moving averages and Bollinger Bands

Price and moving averages has closed above its Short term moving average. Short term moving average is currently below mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is NEUTRAL in short-term; and NEUTRAL in mid-long term.
SNGX has closed below upper band by 35.5%. Bollinger Bands are 38% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

Headline News

Tue, 15 Sep 2020
Soligenix, Inc. (SNGX) Reports Publication Demonstrating Thermostabilization of Filovirus Vaccine Antigens -

Fri, 11 Sep 2020
Is Soligenix’s (NASDAQ:SNGX) Share Price Gain Of 123% Well Earned? - Simply Wall St

Fri, 11 Sep 2020
SNGX: Update and Q&A on COVID-19 Vaccine Candidate CiVax™… - Yahoo Finance

Thu, 10 Sep 2020
Soligenix Announces Investor Webcast Event and Presentation Today: Advantages of the CiVax™ Program for Development of a Broadly Distributed Heat Stable COVID-19 Vaccine - Yahoo Finance

Wed, 09 Sep 2020
Is Soligenix, Inc. Common Stock (SNGX) the Top Pick in the Biotechnology Industry? - InvestorsObserver

Thu, 03 Sep 2020
How Much Is Soligenix's (NASDAQ:SNGX) CEO Getting Paid? - Yahoo Finance

Financial Analysis

Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Price to Book Value: Outperform Discounted cash flow: Outperform
Return on Assets: Underperform Price to Earnings: Underperform
Return on Equity: Underperform Debt to Equity: Outperform
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  NASDAQ
Sector:  Healthcare
Industry:  Biotechnology
Shares Out. (M) 30
Shares Float (M) 30
% Held by Insiders 3.54
% Held by Institutions 8.83
Shares Short (K) 669
Shares Short P. Month (K) 659

Stock Financials

EPS -0.699
EPS Est This Year
EPS Est Next Year
Book Value (p.s.) 0.210
Profit Margin
Operating Margin -515.24
Return on Assets (ttm) -101.2
Return on Equity (ttm) -330.0
Qtrly Rev. Growth -67.3
Gross Profit (p.s.) 0.036
Sales Per Share 0.113
EBITDA (p.s.) -0.580
Qtrly Earnings Growth
Operating Cash Flow (M) -9
Levered Free Cash Flow (M) -9

Stock Valuations

PE Ratio -2.82
PEG Ratio
Price to Book value 9.38
Price to Sales 17.45
Price to Cash Flow -6.50

Stock Dividends

Forward Dividend
Dividend Yield
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.
7 Binary Options
Your Ad Here
Stock Chart
Stoxline Lite
Stoxline Pro
Option Calculator
(c) 2006-2020 | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the web site, a user agrees not to redistribute the information found therein.